Showing results (141-150 of 186) with videos related to
Sort By:
Pageof 19
BMC Gastroenterology|July 16, 2022
A dynamic predictive nomogram of long-term survival in primary gastric lymphoma: a retrospective studyJinru Yang, Tao Liu, Ying Zhu, et al.International Journal of Biological Macromolecules|March 9, 2025
Computational mining and redesign of superoxide dismutase with activity-thermostability improvementGongrui Meng, Lin Li, Lefei Wang, et al.BMC Cancer|April 17, 2025
CD5 and p53 immunohistochemistry: valuable prediction method in molecular typing of CD5-positive diffuse large B-cell lymphomaHan Wang, Huaxiong Pan, Liling Zhang, et al.EMBO Molecular Medicine|May 20, 2020
The role of interleukin-6 in monitoring severe case of coronavirus disease 2019Tao Liu, Jieying Zhang, Yuhui Yang, et al.Journal of Cancer Research and Therapeutics|January 10, 2025
Polatuzumab vedotin plus bendamustine and rituximab in relapsed/refractory diffuse large B-cell lymphoma: A phase III bridging study in Chinese patientsYuqin Song, Qingyuan Zhang, Qingqing Cai, et al.Leukemia & Lymphoma|January 8, 2025
Pharmacokinetics, efficacy, and safety of subcutaneous versus intravenous rituximab in previously untreated Chinese patients with CD20+ diffuse large B-cell lymphoma: a phase II randomized controlled trialYan Gao, Liling Zhang, Sujun Gao, et al.International Journal of Cancer|February 28, 2025
Pirtobrutinib in Chinese patients with relapsed or refractory B-cell malignancies: A single-arm, open-label, phase 2, multicenter trialYanyan Liu, Ningjing Lin, Shuhua Yi, et al.International Journal of Radiation Oncology, Biology, Physics|November 25, 2020
Polymorphonuclear-MDSCs Facilitate Tumor Regrowth After Radiation by Suppressing CD8+ T CellsJieying Zhang Md, Liling Zhang Md, Yuhui Yang Md, et al.Cell Transplantation|April 17, 2026
Total marrow irradiation-based conditioning for allogeneic hematopoietic stem cell transplantation in patients with hematologic malignancies: A multicenter real-world studyYi Zhang, Ran Zhang, Xiena Cao, et al.Blood Advances|March 13, 2026
Phase 1 Study of Zanubrutinib Plus Lenalidomide in Patients With Relapsed/Refractory Diffuse Large B-Cell LymphomaZheng Song, Ying Cheng, Haiyan Yang, et al.Pageof 19